Vascular Disease and Surgery


Heart transplantation surgery has become the standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-transplant care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of heart transplant recipients.

The number of heart transplants performed worldwide over the last decade has continued to increase annually.

Current challenges include older age of both recipients and donors; an increasing number of transplants performed with mechanical circulatory support; the growing use of combined organ transplants (now more than 4% of all heart transplants); and a high proportion of sensitised patients (those with pre-formed antibodies against human leukocyte antigens, which increased the risk of organ rejection).


Cryo Maze for the Safe and Effective Surgical Treatment of Atrial Fibrillation


US Cardiology 2004;1(1):156–7

Using Computational Fluid Dynamics to Examine the Hemodynamics of Artificial Heart Valves


US Cardiology 2004;1(1):1–5

Benefits of Nanotechnology in Cardiovascular Surgery—A Review of Potential Applications


US Cardiology 2006;3(1):95–6

Cellular Signal Transduction Pathways for Anesthetic-induced Cardioprotection


US Cardiology 2006;3(1):93–4